2 completed. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
Follow Blushing: new trials by email Literature Review of Blushing trials Research Report on Blushing
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Masitinib in Severe Indolent or Smoldering Systemic Mastocytosis Masitinib, Placebo, Best Supportive Care - Indolent Systemic Mastocytosis | Phase 3 | Completed | AB Science | 135 | 2008-12-01 | 2019-12-03 |
| Gabapentin for the Treatment of Hot Flashes in Menopausal Women gabapentin - Hot Flashes, Menopause | Phase 3 | Completed | North Toronto Primary Care Research Network | 200 | 2004-03-01 | 2011-05-23 |
Hot Flashes (1) · Mastocytosis (1) · Mastocytosis, Systemic (1) · Piebaldism (1) · Pruritus (1)
Behavior (2) · Communication (2) · Nonverbal Communication (2) · Pathological Conditions, Signs and Symptoms (2) · Signs and Symptoms (2) · Albinism (1) · Amino Acid Metabolism, Inborn Errors (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Eye Diseases, Hereditary (1) · Genetic Diseases, Inborn (1) · Hypopigmentation (1) · Immune System Diseases (1) · Mast Cell Activation Disorders (1) · Metabolic Diseases (1) · Metabolism, Inborn Errors (1)
Gabapentin (1) · masitinib (1)
AB Science (1) · North Toronto Primary Care Research Network (1)
Canada (1) · France (1) · United States (1)
Debra Butt, MSc MD CCFP (1) · Olivier Lortholary, MD, PhD (1)